Diabetes technology

Neural-Net Artificial Pancreas: A Randomized Crossover Trial of a First-in-Class Automated Insulin Delivery Algorithm

Diabetes Technol TherPublished Randomised crossover trial

Primary result · TIRResult — go to the resultDifference 1 percentage point

Authors' conclusion

In a randomized crossover study, a neural-network encoding of a complex model-predictive control algorithm demonstrated similar performance, at a fraction of the computational demands.

Study context

Population
Automated insulin delivery (AID) users with T1D; ages 22–68 years, diabetes duration 7–58 years, 10/5 female/male, baseline HbA1c 5.4%-8.1%17 recruited
Participants
15 users
Comparison
Neural-Net Artificial Pancreas vs original UMPC AID algorithm
Methodological detailspilot-feasibility, two consecutive 20-h hotel sessions
  • Pilot-feasibility
  • Two consecutive 20-h hotel sessions

Primary result

Time-in-range (TIR)

Difference

1 percentage point

By group

As reported in the abstract

Further findings

Coefficient of variation

Time <70 mg/dL

The two algorithms achieved similar times <70 mg/dL
2.0% versus 1.8%

Insulin recommendation under identical inputs

Average absolute insulin-recommendation difference
0.031 U/h

Computational demands

NAP had sixfold lower computational demands than UMPC

Safety

No serious adverse events on either controller

Original publication

Neural-Net Artificial Pancreas: A Randomized Crossover Trial of a First-in-Class Automated Insulin Delivery Algorithm. Diabetes Technol Ther. Published 30 May 2024. doi:10.1089/dia.2023.0469

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.